Climate Change Data

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:58,349.4 tonnes of carbon dioxide equivalent
Scope 1 Emissions:24,355.2 tonnes of carbon dioxide equivalent
Scope 2 Emissions:33,994.2 tonnes of carbon dioxide equivalent
Total Energy Consumption:182,147.3 kWh in '000s
Water Consumption:853,385 m3
Waste Generated:685.1 tonnes (Hazardous: 151.3 tonnes, Non-hazardous: 589.0 tonnes)
Carbon Intensity:4,167.8 tonnes of carbon dioxide equivalent/production line

ESG Focus Areas

  • Environmental Protection
  • Employment and Labor Practices
  • Business Practices
  • Community Investment

Environmental Achievements

  • All factories in Shenzhen obtained Clean Production Certification.
  • Greenhouse gas emissions in Scope 1 and Scope 2 were lower than the previous year.
  • Implemented energy-saving measures to reduce energy consumption and greenhouse gas emissions.
  • Over 90% of laser toner cartridges were recyclable.

Social Achievements

  • Established a comprehensive online learning platform for employee training.
  • Engaged a third-party occupational health assessment unit to conduct a safety assessment.
  • Implemented measures to minimize harm from the COVID-19 outbreak.
  • Established product recall procedures and relevant policies.

Governance Achievements

  • Established a risk management and internal control system.
  • Formulated comprehensive anti-corruption policies.
  • Established reporting channels and investigation mechanisms for corruption.

Climate Goals & Targets

Environmental Challenges

  • Extreme weather destabilizing supply of raw materials and causing workflow delays.
  • Tightening regulatory requirements related to climate change increasing operating costs.
  • Growing market concern about climate change increasing demand for environmentally friendly products.
Mitigation Strategies
  • Developed alternative sourcing strategies and established multiple supply channels.
  • Implemented energy-saving and emission-reduction measures and exceeded regulatory requirements.
  • Enhanced disclosure of ESG performance to improve reputation.

Supply Chain Management

Supplier Audits: 942 suppliers assessed during the Reporting Year

Responsible Procurement
  • Comprehensive review of supplier quality, environmental, and safety performance.
  • Requirement for materials to meet pharmaceutical use requirements.
  • Regular evaluation and monitoring of supplier quality assurance and risk management capabilities.

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather affecting raw material supply and workflow.
Transition Risks
  • Tightening regulatory requirements related to climate change.

Reporting Standards

Frameworks Used: HKEX’s Environmental, Social and Governance Reporting Guide

Certifications: Clean Production Certification, ISO 14001:2015, ISO 9001